“…Tetrahydrocannabinol (THC), the primary psychoactive component of Cannabis sativa, is accompanied in most consumer-ready products by a slew of minor cannabinoids, most notably CBD, which is nonpsychoactive. In recent years, the synthetic production of THC variants, − such as Δ 8 -THC and Δ 9 -THC, has become a focal point within the hemp industry, presenting both opportunities and challenges. While the potential therapeutic benefits of cannabinoids are widely acknowledged, a recent surge in popularity and availability of these products raises concerns about their quality, safety, and legality.…”